Search
for
Sort by
Research 421–450 of 1000+
- Treatment of lichen planopilaris with Janus kinase inhibitors
- Olumiant® (Baricitinib)-A Newly Approved Janus Kinase Inhibitor for the Treatment of Alopecia Areata.
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Review of modern methods of treating vitiligo
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- JAK inhibitors and alopecia areata
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Hair today, gone tomorrow
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- The JAK/STAT signaling pathway: from bench to clinic
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis